Original Article

The Serpin Proteinase Inhibitor 9 Is an Endogenous Inhibitor of Interleukin 1ß–converting Enzyme (Caspase-1) Activity in Human Vascular Smooth Muscle Cells

Correspondence to: Peter Libby, Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 221 Longwood Ave., LMRC 307, Boston, MA 02115. Tel:617-732-6628 Fax:617-732-6961 E-mail:plibby{at}rics.bwh.harvard.edu.

Interleukin-1ß–converting enzyme (ICE, caspase-1) regulates key steps in inflammation and immunity, by activating the proinflammatory cytokines interleukin (IL-)1ß and IL-18, or mediating apoptotic processes. We recently provided evidence for the regulation of caspase-1 activity via an endogenous inhibitor expressed by human vascular smooth muscle cells (SMCs) (Schönbeck, U., M. Herzberg, A. Petersen, C. Wohlenberg, J. Gerdes, H.-D. Flad, and H. Loppnow. 1997. J. Exp. Med. 185:1287–1294). However, the molecular identity of this endogenous inhibitor remained undefined. We report here that the serine proteinase inhibitor (serpin) PI-9 accounts for the endogenous caspase-1 inhibitory activity in human SMCs and prevents processing of the enzyme's natural substrates, IL-1ß and IL-18 precursor. Treatment of SMC lysates with anti–PI-9 antibody abrogated the caspase-1 inhibitory activity and coprecipitated the enzyme, demonstrating protein–protein interaction. Furthermore, PI-9 antisense oligonucleotides coordinately reduced PI-9 expression and promoted IL-1ß release. Since SMCs comprise the majority of cells in the vascular wall, and because IL-1 is implicated in atherogenesis, we tested the biological validity of our in vitro findings within human atheroma in situ. The unaffected arterial wall contains abundant and homogeneously distributed PI-9. In human atherosclerotic lesions, however, PI-9 expression correlated inversely with immunoreactive IL-1ß, supporting a potential role of the endogenous caspase-1 inhibitor in this chronic inflammatory disease. Thus, our results provide new insights into the regulation of this enzyme involved in immune and inflammatory processes of chronic inflammatory diseases, and point to an endogenous antiinflammatory action of PI-9, dysregulated in a prevalent human disease.

Key Words: caspase-1, interleukin 1ß, PI-9, smooth muscle cells, atherosclerosis

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Li, J., Yin, H. L., Yuan, J. (2008). Flightless-I regulates proinflammatory caspases by selectively modulating intracellular localization and caspase activity. J. Cell Biol. 181: 321-333 [Abstract] [Full Text]  
• Nadiri, A., Wolinski, M. K., Saleh, M. (2006). The Inflammatory Caspases: Key Players in the Host Response to Pathogenic Invasion and Sepsis. J. Immunol. 177: 4239-4245 [Abstract] [Full Text]  
• Petrache, I., Fijalkowska, I., Medler, T. R., Skirball, J., Cruz, P., Zhen, L., Petrache, H. I., Flotte, T. R., Tuder, R. M. (2006). {alpha}-1 Antitrypsin Inhibits Caspase-3 Activity, Preventing Lung Endothelial Cell Apoptosis. Am. J. Pathol. 169: 1155-1166 [Abstract] [Full Text]  
• Petrache, I., Fijalkowska, I., Zhen, L., Medler, T. R., Brown, E., Cruz, P., Choe, K.-H., Taraseviciene-Stewart, L., Scerbavicius, R., Shapiro, L., Zhang, B., Song, S., Hicklin, D., Voelkel, N. F., Flotte, T., Tuder, R. M. (2006). A Novel Antiapoptotic Role for {alpha}1-Antitrypsin in the Prevention of Pulmonary Emphysema. Am. J. Respir. Crit. Care Med. 173: 1222-1228 [Abstract] [Full Text]  
• Jiang, X., Orr, B. A., Kranz, D. M., Shapiro, D. J. (2006). Estrogen Induction of the Granzyme B Inhibitor, Proteinase Inhibitor 9, Protects Cells against Apoptosis Mediated by Cytotoxic T Lymphocytes and Natural Killer Cells. Endocrinology 147: 1419-1426 [Abstract] [Full Text]  
• Bezzina Wettinger, S., Doggen, C. J. M., Spek, C. A., Rosendaal, F. R., Reitsma, P. H. (2005). High throughput mRNA profiling highlights associations between myocardial infarction and aberrant expression of inflammatory molecules in blood cells. Blood 105: 2000-2006 [Abstract] [Full Text]  
• Bots, M., Kolfschoten, I. G. M., Bres, S. A., Rademaker, M. T. G. A., de Roo, G. M., Kruse, M., Franken, K. L. M. C., Hahne, M., Froelich, C. J., Melief, C. J. M., Offringa, R., Medema, J. P. (2005). SPI-CI and SPI-6 cooperate in the protection from effector cell-mediated cytotoxicity. Blood 105: 1153-1161 [Abstract] [Full Text]  
• Krettek, A., Sukhova, G. K., Schonbeck, U., Libby, P. (2004). Enhanced Expression of CD44 Variants in Human Atheroma and Abdominal Aortic Aneurysm: Possible Role for a Feedback Loop in Endothelial Cells. Am. J. Pathol. 165: 1571-1581 [Abstract] [Full Text]  
• Montero, M. T., Matilla, J., Gomez-Mampaso, E., Lasuncion, M. A. (2004). Geranylgeraniol Regulates Negatively Caspase-1 Autoprocessing: Implication in the Th1 Response against Mycobacterium tuberculosis. J. Immunol. 173: 4936-4944 [Abstract] [Full Text]  
• Krieg, A. J., Krieg, S. A., Ahn, B. S., Shapiro, D. J. (2004). Interplay between Estrogen Response Element Sequence and Ligands Controls in Vivo Binding of Estrogen Receptor to Regulated Genes. J. Biol. Chem. 279: 5025-5034 [Abstract] [Full Text]  
• Von der Thusen, J. H., Kuiper, J., Van Berkel, T. J. C., Biessen, E. A. L. (2003). Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential. Pharmacol. Rev. 55: 133-166 [Abstract] [Full Text]  
• Joshi, V. D., Kalvakolanu, D. V., Hebel, J. R., Hasday, J. D., Cross, A. S. (2002). Role of Caspase 1 in Murine Antibacterial Host Defenses and Lethal Endotoxemia. Infect. Immun. 70: 6896-6903 [Abstract] [Full Text]  
• Kannan-Thulasiraman, P., Shapiro, D. J. (2002). Modulators of Inflammation Use Nuclear Factor-kappa B and Activator Protein-1 Sites to Induce the Caspase-1 and Granzyme B Inhibitor, Proteinase Inhibitor 9. J. Biol. Chem. 277: 41230-41239 [Abstract] [Full Text]  
• Korkmaz, B., Attucci, S., Hazouard, E., Ferrandiere, M., Jourdan, M. L., Brillard-Bourdet, M., Juliano, L., Gauthier, F. (2002). Discriminating between the Activities of Human Neutrophil Elastase and Proteinase 3 Using Serpin-derived Fluorogenic Substrates. J. Biol. Chem. 277: 39074-39081 [Abstract] [Full Text]  
• Schonbeck, U., Sukhova, G. K., Gerdes, N., Libby, P. (2002). TH2 Predominant Immune Responses Prevail in Human Abdominal Aortic Aneurysm. Am. J. Pathol. 161: 499-506 [Abstract] [Full Text]  
• ten Berge, R. L., Meijer, C. J. L. M., Dukers, D. F., Kummer, J. A., Bladergroen, B. A., Vos, W., Hack, C. E., Ossenkoppele, G. J., Oudejans, J. J. (2002). Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma. Blood 99: 4540-4546 [Abstract] [Full Text]  
• Leoni, F., Zaliani, A., Bertolini, G., Porro, G., Pagani, P., Pozzi, P., Dona, G., Fossati, G., Sozzani, S., Azam, T., Bufler, P., Fantuzzi, G., Goncharov, I., Kim, S.-H., Pomerantz, B. J., Reznikov, L. L., Siegmund, B., Dinarello, C. A., Mascagni, P. (2002). The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines. Proc. Natl. Acad. Sci. USA 10.1073/pnas.052702999v1 [Abstract] [Full Text]  
• Gerdes, N., Sukhova, G. K., Libby, P., Reynolds, R. S., Young, J. L., Schonbeck, U. (2002). Expression of Interleukin (IL)-18 and Functional IL-18 Receptor on Human Vascular Endothelial Cells, Smooth Muscle Cells, and Macrophages: Implications for Atherogenesis. J. Exp. Med. 195: 245-257 [Abstract] [Full Text]  
• Bladergroen, B. A., Meijer, C. J. L. M., ten Berge, R. L., Hack, C. E., Muris, J. J. F., Dukers, D. F., Chott, A., Kazama, Y., Oudejans, J. J., van Berkum, O., Kummer, J. A. (2002). Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?. Blood 99: 232-237 [Abstract] [Full Text]  
• Hirst, C. E., Buzza, M. S., Sutton, V. R., Trapani, J. A., Loveland, K. L., Bird, P. I. (2001). Perforin-independent expression of granzyme B and proteinase inhibitor 9 in human testis and placenta suggests a role for granzyme B-mediated proteolysis in reproduction. Mol Hum Reprod 7: 1133-1142 [Abstract] [Full Text]  
• Krieg, S. A., Krieg, A. J., Shapiro, D. J. (2001). A Unique Downstream Estrogen Responsive Unit Mediates Estrogen Induction of Proteinase Inhibitor-9, a Cellular Inhibitor of IL-1{beta}- Converting Enzyme (Caspase 1). Mol. Endocrinol. 15: 1971-1982 [Abstract] [Full Text]  
• Ogbourne, S. M., Antalis, T. M. (2001). Characterisation of PAUSE-1, a powerful silencer in the human plasminogen activator inhibitor type 2 gene promoter. Nucleic Acids Res 29: 3919-3927 [Abstract] [Full Text]  
• Tedgui, A., Mallat, Z. (2001). Anti-Inflammatory Mechanisms in the Vascular Wall. Circ. Res. 88: 877-887 [Abstract] [Full Text]  
• Bladergroen, B. A., Strik, M. C. M., Bovenschen, N., van Berkum, O., Scheffer, G. L., Meijer, C. J. L. M., Hack, C. E., Kummer, J. A. (2001). The Granzyme B Inhibitor, Protease Inhibitor 9, Is Mainly Expressed by Dendritic Cells and at Immune-Privileged Sites. J. Immunol. 166: 3218-3225 [Abstract] [Full Text]  
• Leoni, F., Zaliani, A., Bertolini, G., Porro, G., Pagani, P., Pozzi, P., Dona, G., Fossati, G., Sozzani, S., Azam, T., Bufler, P., Fantuzzi, G., Goncharov, I., Kim, S.-H., Pomerantz, B. J., Reznikov, L. L., Siegmund, B., Dinarello, C. A., Mascagni, P. (2002). The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines. Proc. Natl. Acad. Sci. USA 99: 2995-3000 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS